Michael T. Collins

15.9k citations

233 papers · 9.8k indexed · 1 hit paper · h-index 58

Impact in

Nephrology top 0.05%
- Parathyroid Disorders and Treatments
Rheumatology top 0.1%
- Bone Tumor Diagnosis and Treatments

Papers in

Nephrology 80
- Parathyroid Disorders and Treatments 79
Rheumatology 107
- Bone Tumor Diagnosis and Treatments 94

Co-authors: Alison M. Boyce Pamela Gehron Robey Rachel I. Gafni Marilyn H Kelly William H Chong Beth A Brillante Paolo Bianco Clara C. Chen
Journals: Journal of Bone and Mineral Research (47 papers)The Journal of Clinical Endocrinology & Metabolism (27 papers)Osteoporosis International (11 papers)Bone (7 papers)Orphanet Journal of Rare Diseases (5 papers)
Partner nations: United States Italy Chile

In The Last Decade

Michael T. Collins

220 papers receiving 9.6k citations

Hit Papers

align trajectories log scale

Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research 2011 · 366 citations

Peers

Countries citing papers authored by Michael T. Collins

Since Specialization

Citations

This map shows the geographic impact of Michael T. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Collins more than expected).

Fields of papers citing papers by Michael T. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Collins. The network helps show where Michael T. Collins may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael T. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael T. Collins Line = papers co-authored together Michael T. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A mouse model of Jansen’s metaphyseal chondrodysplasia for investigating disease mechanisms and candidate therapeutics Proceedings of the National Academy of Sciences ·Daniela Chavarría-Guevara, 正文菊田, Xianlin Lv, Monica Reyes, Patrick Hanna, Prem Swaroop Yadav, Thomas Dean, Karla M. Ramos‐Torres, Pedro Brugarolas, Michael T. Collins, Marc N. Wein, І. С. Мостова, Samuel H. Gellman, Ernestina Schipani, Henry M. Kronenberg, Thomas J. Gardella, H. Jüppner	2025	2
2	12520 Preliminary Findings From An Ongoing Open-label Phase 2 Study Demonstrate That The Calcilytic Encaleret Can Improve The Relationship Between Blood And Urinary Calcium In Individuals With Post-surgical Hypoparathyroidism Journal of the Endocrine Society ·Ian R. Hartley, Rachel I. Gafni, Kelly L. Roszko, Xiaorong Li, E. S. Belenk'aya, Cynthia A. Moore, 谷森達, 祐造本田, Arani Sridhar, Xin Daphne Hou, Mary Scott Roberts, Scott Adler, Edward F. Nemeth, Michael T. Collins	2024	1
3	Retrospective Single Nucleotide Polymorphism Analysis of Host Resistance and Susceptibility to Ovine Johne’s Disease Using Restored FFPE DNA International Journal of Molecular Sciences ·V.A. Savushkin, Lee Sanghoon, Gota Morota, T. Nicol, Rebecca Cockrum, Robert Chr. Thomsen, Charoula Theofanous, Michael T. Collins, Nammalwar Sriranganathan	2024	0
4	OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629) Journal of the Endocrine Society ·Rachel I. Gafni, Iris R. Hartley, Kelly L. Roszko, Edward F. Nemeth, 谷森達, Chenxiao Lin, Mary Scott Roberts, Scott Adler, Michael T. Collins	2023	0
5	Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source Journal of Clinical Investigation ·Diana Ovejero, 瑞生頼松, Christophe Cataisson, 和彦野々村, Rebeca Galisteo, Stuart H. Yuspa, Michael T. Collins, Luis F de Castro	2023	6
6	Coxa Vara Deformity in Fibrous Dysplasia/ McCune‐Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two‐Center Study Journal of Bone and Mineral Research ·Jinchi Guo, Natasha M. Appelman‐Dijkstra, Michael T. Collins, Raehan Royan, Robert P. Stanton, Pieter Bas de Witte, Alison M. Boyce, Michiel A. J. van de Sande	2023	2
7	Identification of GNAS Variants in Circulating Cell‐Free DNA from Patients with Fibrous Dysplasia/ McCune Albright Syndrome Journal of Bone and Mineral Research ·Kelly L. Roszko, Lori C. Guthrie, Xiaobai Li, Michael T. Collins, Luis F de Castro, Alison M. Boyce	2023	15
8	Author Correction: Skeletal and extraskeletal disorders of biomineralization Nature Reviews Endocrinology ·Michael T. Collins, Gemma Marcucci, Hans‐Joachim Anders, Giovanni Beltrami, Jane A. Cauley, Peter R. Ebeling, Rajiv Kumar, Agnès Linglart, Luca Sangiorgi, Dwight A. Towler, Ria Weston, A Mugnier, Maria Luisa Brandi, B.L. Clarke, Rajesh V. Thakker	2022	1
9	Skeletal and extraskeletal disorders of biomineralization Nature Reviews Endocrinology ·Michael T. Collins, Gemma Marcucci, Hans‐Joachim Anders, Blandine Grousset, Jane A. Cauley, Peter R. Ebeling, Rajiv Kumar, Agnès Linglart, Luca Sangiorgi, Dwight A. Towler, Ria Weston, Michael P. Whyte, Maria Luisa Brandi, B.L. Clarke, Rajesh V. Thakker	2022	41
10	Abstract 14476: Effects of Encaleret on Corrected QT Interval in Autosomal Dominant Hypocalcemia Type 1: Early Results From an Ongoing Phase 2b, Open-Label, Dose-Ranging Study Circulation ·Iris R. Hartley, Rachel I. Gafni, Kelly L. Roszko, 谷森達, Michael T. Collins, Edward F. Nemeth, Zhengao Di, 高立娣, Lyndsay M. Stapleton, Mary Scott Roberts, Nurhapipa Nurhapipa	2021	0
11	Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia Journal of Bone and Mineral Research ·Iris R. Hartley, Rachel I. Gafni, Kelly L. Roszko, Karel Vermeyen, Luis F de Castro, 和彦野々村, Carlos R. Ferreira, William A. Gahl, Karel Pacák, Jenny E. Blau, Alison M. Boyce, Isidro B. Salusky, Michael T. Collins, Pablo Florenzano	2020	18
12	Neonatal McCune‐Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome JBMR Plus ·Alessandro Corsi, Natasha Cherman, David Donaldson, Pamela Gehron Robey, Michael T. Collins, Mara Riminucci	2018	10
13	Skeletal Consequences of Nephropathic Cystinosis Journal of Bone and Mineral Research ·Pablo Florenzano, Carlos R. Ferreira, Galina Nesterova, Mary Scott Roberts, Sri Harsha Tella, Luis F de Castro, Karel Vermeyen, Zakaria Habib Al-Ra’zie, Renata C. Pereira, Dorothy Bulas, Rachel I. Gafni, Isidro B. Salusky, William A. Gahl, Michael T. Collins	2018	21
14	Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study JCI Insight ·Jenny E. Blau, Viviana Bauman, S.M.C.T.Siriwardhana, Paolo Piaggi, Mary Walter, Elizabeth C. Wright, Shanna Bernstein, Amber B. Courville, Michael T. Collins, Kristina I. Rother, Simeon I. Taylor	2018	118
15	Expression of an active Gα_smutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance Proceedings of the National Academy of Sciences ·Xuefeng Zhao, Peng Deng, Ramiro Iglesias‐Bartolomé, Panomwat Amornphimoltham, Dana J. Steffen, Yunyun Jin, Alfredo Molinolo, Luis F de Castro, Diana Ovejero, Quan Yuan, Qianming Chen, Xianglong Han, Ding Bai, Susan S. Taylor, Yingzi Yang, Michael T. Collins, J. Silvio Gutkind	2017	47
16	Fibrous Dysplasia/McCune-Albright Syndrome Alison M. Boyce, Michael T. Collins	2015	62
17	A Randomized, Double Blind, Placebo-Controlled Trial of Alendronate Treatment for Fibrous Dysplasia of Bone The Journal of Clinical Endocrinology & Metabolism ·Alison M. Boyce, Marilyn H Kelly, Beth A Brillante, Harvey Kushner, Shlomo Wientroub, Mara Riminucci, Paolo Bianco, Pamela Gehron Robey, Michael T. Collins	2014	94
18	Age-Dependent Demise of GNAS -Mutated Skeletal Stem Cells and “Normalization” of Fibrous Dysplasia of Bone Journal of Bone and Mineral Research ·Sergei A. Kuznetsov, Natasha Cherman, Mara Riminucci, Michael T. Collins, Pamela Gehron Robey, Paolo Bianco	2008	106
19	The Role of Type 1 and Type 2 5′-Deiodinase in the Pathophysiology of the 3,5,3′-Triiodothyronine Toxicosis of McCune-Albright Syndrome The Journal of Clinical Endocrinology & Metabolism ·Francesco S. Celi, Giuseppe Coppotelli, Aaron Chidakel, Marilyn Kelly, Beth A Brillante, Thomas H. Shawker, Natasha Cherman, Penelope Feuillan, Michael T. Collins	2008	42
20	FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting Journal of Clinical Investigation ·Mara Riminucci, Michael T. Collins, Neal S. Fedarko, Natasha Cherman, Alessandro Corsi, Kenneth E. White, Steven G. Waguespack, Anurag Gupta, Tamara S. Hannon, Michael J. Econs, Paolo Bianco, Pamela Gehron Robey	2003	39

About Michael T. Collins

Michael T. Collins is a scholar working on Nephrology, Rheumatology, Oral Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 233 papers that have together received 9.8k indexed citations. Recurring topics across this work include Bone health and treatments (96 papers), Bone Tumor Diagnosis and Treatments (94 papers), Parathyroid Disorders and Treatments (79 papers), Oral and Maxillofacial Pathology (39 papers), Medical Imaging and Pathology Studies (34 papers), Genetic Syndromes and Imprinting (22 papers), Sarcoma Diagnosis and Treatment (22 papers) and Histiocytic Disorders and Treatments (20 papers). The work is most often cited by research in Nephrology (3.6k citations), Rheumatology (3.9k citations), Oral Surgery (1.6k citations), Oncology (3.3k citations) and Endocrinology, Diabetes and Metabolism (1.1k citations). Michael T. Collins has collaborated with scholars based in United States, Italy and Chile. Frequent co-authors include Alison M. Boyce, Pamela Gehron Robey, Rachel I. Gafni, Marilyn H Kelly, William H Chong, Beth A Brillante, Paolo Bianco, Clara C. Chen, Mara Riminucci and Natasha Cherman. Their work appears in journals such as Journal of Bone and Mineral Research, The Journal of Clinical Endocrinology & Metabolism, Osteoporosis International, Bone and Orphanet Journal of Rare Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact